2023 Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Juan Carlos Hernández-Boluda Journal Bone Marrow Transplant.
2023 Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Rémi Tilmont Journal Bone Marrow Transplant.
2023 Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial Group Chronic Malignancies Working Party (CMWP) 1st listed author Thomas Schroeder Journal Haematologica.
2023 A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author Roni Tamari Journal Blood Adv.
2023 Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Bone Marrow Transplant.
2023 Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study Group Chronic Malignancies Working Party (CMWP) 1st listed author Nico Gagelmann Journal Eur J Haematol.
2023 The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Olivier Tournilhac Journal Bone Marrow Transplant.
2023 Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Hemasphere.
2023 An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Meral Beksac Journal Bone Marrow Transplant.
2023 Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE) Group Acute Leukemia Working Party (ALWP) Severe Aplastic Anaemia Working Party (SAAWP) Autoimmune Diseases Working Party (ADWP) Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Inborn Errors Working Party (IEWP) Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Lymphoma Working Party (LWP) Paediatric Diseases Working Party (PDWP) JACIE Committee 1st listed author Riccardo Saccardi Journal Bone Marrow Transplant.
2023 Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Anna Waszczuk-Gajda Journal Bone Marrow Transplant.
2023 Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation Group Chronic Malignancies Working Party (CMWP) 1st listed author Guillermo Ortí Journal Am J Hematol.